Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Liquivisc 0.25% eye gel
1108010Z0BBAAAA
|
Liquivisc | Carbomer 974P | Eye | 1,737 |
|
Iopidine 1% eye drops 0.25ml unit dose
1108020J0BBAAAA
|
Iopidine | Apraclonidine | Eye | 1,694 |
|
Dexamethasone 0.1% / Tobramycin 0.3% eye drops
1104010I0AAAPAP
|
Dexamethasone (Eye) | Dexamethasone | Eye | 1,670 |
|
Apraclonidine 1% eye dps 0.25ml unit dose preservative free
1108020J0AAAAAA
|
Apraclonidine hydrochloride | Apraclonidine | Eye | 1,655 |
|
Carbomer 0.36% eye gel preservative free
1108030AAAAABAB
|
Carbomer | Carbomer | Eye | 1,630 |
|
Optrex Allergy 2% eye drops
1104020T0BHAAAA
|
Optrex Allergy | Sodium cromoglicate | Eye | 1,607 |
|
Pilocarpine hydrochloride 1% eye drops
1106000X0AAABAB
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | 1,568 |
|
Visutrax 40micrograms/ml eye drops 0.1ml unit dose
1106000AEBDAAAB
|
Visutrax | Travoprost | Eye | 1,420 |
|
Aciclovir 30mg/g eye ointment
1103030C0AAAAAA
|
Aciclovir (Eye) | Aciclovir | Eye | 1,397 |
|
Eydelto 20mg/ml eye drops
1106000P0BDAAAC
|
Eydelto | Dorzolamide | Eye | 1,392 |
|
Catacrom 2% eye drops 0.3ml unit dose
1104020T0BSAAAJ
|
Catacrom | Sodium cromoglicate | Eye | 1,384 |
|
Levobunolol 0.5% eye drops 0.4ml unit dose preservative free
1106000T0AAABAB
|
Levobunolol hydrochloride | Levobunolol hydrochloride | Eye | 1,332 |
|
Antazoline 0.5% / Xylometazoline 0.05% eye drops
1104020B0AAACAC
|
Antaz sulf (Eye) | Antazoline | Eye | 1,285 |
|
Yellox 900micrograms/ml eye drops
1108020AGBBAAAA
|
Yellox | Bromfenac | Eye | 1,266 |
|
Moxifloxacin 0.5% eye drops
1108020U0AAABAB
|
Moxifloxacin hydrochloride (Eye) | Moxifloxacin hydrochloride | Eye | 1,234 |
|
Hypromellose 0.32% eye drops
1108010F0AABNBN
|
Hypromellose | Hypromellose | Eye | 1,206 |
|
Bromfenac 900micrograms/ml eye drops
1108020AGAAAAAA
|
Bromfenac | Bromfenac | Eye | 1,166 |
|
Betoptic 0.5% eye drops
1106000I0BBAAAA
|
Betoptic | Betaxolol | Eye | 1,116 |
|
Acetazolamide 250mg modified-release capsules
1106000B0AAALAL
|
Acetazolamide | Acetazolamide | Eye | 1,085 |
|
Dexamethasone 0.1% eye dps 0.3ml unit dose preservative free
1104010I0AAAVAV
|
Dexamethasone (Eye) | Dexamethasone | Eye | 1,031 |
|
Alomide 0.1% eye drops
1104020M0BBAAAA
|
Alomide | Lodoxamide trometamol | Eye | 991 |
|
Tafluprost 15micrograms/ml eye drops
1106000AKAAABAB
|
Tafluprost | Tafluprost | Eye | 989 |
|
Eyreida 0.3mg/ml eye drops
1106000AFBDAAAD
|
Eyreida | Bimatoprost | Eye | 974 |
|
Levofloxacin 5mg/ml eye drops
1103010AGAAAAAA
|
Levofloxacin (Eye) | Levofloxacin | Eye | 936 |
|
Timoptol 0.5% eye drops
1106000Z0BBABAB
|
Timoptol | Timolol | Eye | 928 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.